Huntsman Ronald Kirk's Form 4 filing
Vivos Therapeutics, Inc. (VVOS) · filed Dec 28, 2022
- Accession no.
- 0001493152-22-036727
- Filed
- Dec 28, 2022, 9:45 PM ET
- Trade date
- Dec 23, 2022
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 2 derivative transactions. Open-market purchases total $10.0K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Huntsman Ronald KirkCIK 0001835498 | Director, Officer (Chief Executive Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 23, 2022 | Common Stock | PPurchaseAcquired | +20,000 | $0.50 | +$10,000 | 47,500 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 23, 2022 | Common Stock | AGrant or awardAcquired | +333,334 | $0.48 | +$160,000.32 | 333,334 | Direct | |
| Dec 23, 2022 | Common Stock | AGrant or awardAcquired | +483,334 | $0.48 | +$72,000 | 483,334 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.